Federal contract award
75FCMC23F0021
ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | OFC OF ACQUISITION AND GRANTS MGMT |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | B528 — Regulatory Studies |
| Parent award / vehicle | 47QRAA18D001P |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $15.8M |
| Current contract value | $15.8M |
| Potential contract value / ceiling | $19.1M |
| Start date | May 1, 2023 |
| Current end date | Apr 30, 2027 |
| Potential end date | Apr 30, 2028 |
| Latest award activity | Jun 30, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 30, 2026 | P00009 | $-50.1K | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN (DELOITTE) |
| Apr 24, 2026 | P00008 | $3.9M | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN (DELOITTE) |
| Jun 24, 2025 | P00007 | $801.5K | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN (DELOITTE) |
| Apr 21, 2025 | P00006 | $0 | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN (DELOITTE) |
| Mar 19, 2025 | P00005 | $3.2M | EOI::DEFEND THE SPEND (FEBRUARY 6, 2025)::EOI MODIFICATION TO DESCOPE NON-ESSENTIAL CONSULTING SERVICE |
| Jun 21, 2024 | P00004 | $-605.6K | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN |
| Apr 10, 2024 | P00003 | $4.3M | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN |
| Jul 28, 2023 | P00002 | $0 | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN |
| Jun 23, 2023 | P00001 | $-61.4K | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN |
| Feb 21, 2023 | 0 | $4.3M | ACTUARIAL REVIEW AND ESTIMATES FOR PRESCRIPTION DRUG & MEDICARE ADV PLAN |
Estimated positioning window
Apr 30, 2027 – Oct 30, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2028-04-30 (546 days from calculation)
- +25 points
- 9 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-06-30
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.